| Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC O Rubio‐Cabezas, V Puri, I Murano, V Saudek, RK Semple, S Dash, ... EMBO molecular medicine 1 (5), 280-287, 2009 | 278 | 2009 |
| Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent S Romeo, F Sentinelli, S Dash, GSH Yeo, DB Savage, F Leonetti, ... International journal of obesity 34 (1), 190-194, 2010 | 222 | 2010 |
| Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol C Xiao, S Dash, C Morgantini, RA Hegele, GF Lewis Diabetes 65 (7), 1767-1778, 2016 | 208 | 2016 |
| Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans C Xiao, RHJ Bandsma, S Dash, L Szeto, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1513-1519, 2012 | 173 | 2012 |
| New insights into the regulation of chylomicron production S Dash, C Xiao, C Morgantini, GF Lewis Annual review of nutrition 35, 265-294, 2015 | 172 | 2015 |
| Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications S Sarma, S Sockalingam, S Dash Diabetes, Obesity and Metabolism 23, 3-16, 2021 | 130 | 2021 |
| A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia S Dash, H Sano, JJ Rochford, RK Semple, G Yeo, CSS Hyden, MA Soos, ... Proceedings of the National Academy of Sciences 106 (23), 9350-9355, 2009 | 123 | 2009 |
| High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men S Dash, C Xiao, C Morgantini, L Szeto, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 33 (12), 2895-2901, 2013 | 118 | 2013 |
| Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations S Dash, C Xiao, C Morgantini, K Koulajian, GF Lewis Diabetes 64 (3), 766-774, 2015 | 107 | 2015 |
| Glucagon-like peptide-2 regulates release of chylomicrons from the intestine S Dash, C Xiao, C Morgantini, PW Connelly, BW Patterson, GF Lewis Gastroenterology 147 (6), 1275-1284. e4, 2014 | 93 | 2014 |
| Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans C Xiao, S Dash, C Morgantini, BW Patterson, GF Lewis Diabetes 63 (7), 2394-2401, 2014 | 76 | 2014 |
| New and emerging regulators of intestinal lipoprotein secretion C Xiao, S Dash, C Morgantini, GF Lewis Atherosclerosis 233 (2), 608-615, 2014 | 65 | 2014 |
| Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans C Xiao, S Dash, C Morgantini, GF Lewis Arteriosclerosis, thrombosis, and vascular biology 33 (5), 1056-1062, 2013 | 61 | 2013 |
| Gut peptides are novel regulators of intestinal lipoprotein secretion: experimental and pharmacological manipulation of lipoprotein metabolism C Xiao, S Dash, C Morgantini, K Adeli, GF Lewis Diabetes 64 (7), 2310-2318, 2015 | 56 | 2015 |
| Oral glucose mobilizes triglyceride stores from the human intestine C Xiao, P Stahel, AL Carreiro, YH Hung, S Dash, I Bookman, KK Buhman, ... Cellular and Molecular Gastroenterology and Hepatology 7 (2), 313-337, 2019 | 35 | 2019 |
| Intravenous glucose acutely stimulates intestinal lipoprotein secretion in healthy humans C Xiao, S Dash, C Morgantini, GF Lewis Arteriosclerosis, Thrombosis, and Vascular Biology 36 (7), 1457-1463, 2016 | 31 | 2016 |
| Obesity and cardiovascular disease: the emerging role of inflammation R Khafagy, S Dash Frontiers in Cardiovascular Medicine 8, 768119, 2021 | 22 | 2021 |
| Mechanisms of incretin effects on plasma lipids and implications for the cardiovascular system C Xiao, S Dash, G F Lewis Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2012 | 22 | 2012 |
| Effects of intranasal insulin on endogenous glucose production in insulin‐resistant men C Xiao, S Dash, P Stahel, GF Lewis Diabetes, Obesity and Metabolism 20 (7), 1751-1754, 2018 | 21 | 2018 |
| Dietary carbohydrates and intestinal lipoprotein production C Morgantini, C Xiao, S Dash, GF Lewis Current Opinion in Clinical Nutrition & Metabolic Care 17 (4), 355-359, 2014 | 19 | 2014 |
